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Abstract
Background: Reliable estimates of disease burden associated with respiratory viruses are keys to deployment of preventive
strategies such as vaccination and resource allocation. Such estimates are particularly needed in tropical and subtropical
regions where some methods commonly used in temperate regions are not applicable. While a number of alternative
approaches to assess the influenza associated disease burden have been recently reported, none of these models have
been validated with virologically confirmed data. Even fewer methods have been developed for other common respiratory
viruses such as respiratory syncytial virus (RSV), parainfluenza and adenovirus.
Methods and Findings: We had recently conducted a prospective population-based study of virologically confirmed
hospitalization for acute respiratory illnesses in persons ,18 years residing in Hong Kong Island. Here we used this dataset
to validate two commonly used models for estimation of influenza disease burden, namely the rate difference model and
Poisson regression model, and also explored the applicability of these models to estimate the disease burden of other
respiratory viruses. The Poisson regression models with different link functions all yielded estimates well correlated with the
virologically confirmed influenza associated hospitalization, especially in children older than two years. The disease burden
estimates for RSV, parainfluenza and adenovirus were less reliable with wide confidence intervals. The rate difference model
was not applicable to RSV, parainfluenza and adenovirus and grossly underestimated the true burden of influenza
associated hospitalization.
Conclusion: The Poisson regression model generally produced satisfactory estimates in calculating the disease burden of
respiratory viruses in a subtropical region such as Hong Kong.
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Introduction
Respiratory viruses have been associated with substantial
disease burden in relation to hospitalization and mortality.
Reliable estimates of such disease burden are important to
determine the costs and benefits associated with prevention and
control strategies. Since various respiratory pathogens cannot be
distinguished from each other on clinical features and as the
majority of respiratory disease is not investigated virologically, the
disease burden is usually estimated by statistical models. These
models have so far largely been applied to influenza and to a more
limited extent, to respiratory syncytial virus (RSV). The Center of
Disease Control and Prevention of the United States (USCDC)
has applied a Serfling cyclical regression model to estimate the
baseline mortality by incorporating the long term and seasonal
trends of pneumonia and influenza (P&I) mortality [1]. This model
may not be applicable to subtropical and tropical regions where
seasonal trends of mortality and influenza and other respiratory
virus activity are relatively unpredictable. Even in temperate
regions with well isolated winter peaks of influenza and RSV,
concerns have been raised about the potential confounding effect
of the co-circulation of other respiratory viruses on Serfling model
derived estimates of influenza disease burden [2].
Two other approaches have been used to address these concerns
and also to allow disease burden estimates to be made in
subtropical and tropical regions with more variable and diffuse
influenza virus activity than in temperate regions. One is the rate
difference model (also known as excess rate model) which defines
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minimal threshold of laboratory defined virus activity) and then
calculates rate differences in influenza morbidity by comparing
epidemic and baseline periods [3,4]. This model may allow some
correction for confounding effects of other viruses given the well
separated peaks for different respiratory viruses. Another model is
the Poisson regression model [5,6], which can adjust for
confounding of seasonal trends of disease outcomes, co-circulation
of other respiratory pathogens and other potential confounding
factors. These two methods have been applied in temperate, sub-
tropical and tropical settings with varying degrees of success,
demonstrating substantial influenza associated mortality and
hospitalization that is comparable among different geographic
regions such as the US, Hong Kong and Singapore [3,4,6–9].
Similar approaches of rate difference and Poisson regression
models have been applied to estimate the disease burden
associated with RSV [10–13], but few has been developed for
parainfluenza and adenovirus, which are less predominant causes
of hospitalization than influenza and RSV.
A recent study by Thompson et al. [14] compared the
performance of the Serfling cyclical regression, autoregressive
integrated moving average (ARIMA) model, rate difference model
and Serfling–Poisson regression model in estimating the excess
mortality rates associated with influenza in the US. Both Serfling
regression and ARIMA models may not be applicable to the
subtropical and tropical regions as they need well-separated non-
epidemic periods to define baseline levels of mortality. The latter
two methods require virological surveillance data from the
relevant region to be included in the analysis. The authors
conclude that the Poisson regression models permit estimation of
influenza associated deaths but require robust virological data
while the simple rate difference models may be useful in regions
with sparse viral surveillance data or complex influenza seasonality
[14]. However, none of the estimates from these models have been
validated using a time series of virologically confirmed cases. One
recent Canadian study [15] compared a convenience sample of
virologically confirmed cases of RSV and influenza in children less
than two years of age to validate estimates of hospitalization rates
derived from statistical methods. However, their virologically
confirmed cases were collected from one single hospital which
served only 10% of the population of Quebec province and it may
be difficult to confidently extrapolate these data to the population
denominator. Furthermore, their conclusion may not be applica-
ble to older children or to tropical regions which have more
complex influenza seasonality patterns when compared with
temperate regions. There is thus a need for studies that validate
such statistical estimates of disease burden estimates with directly
observed and virologically confirmed outcomes. In this study we
used the hospitalization data of virologically confirmed cases to
validate two of the above-mentioned methods: rate difference and
Poisson regression models, for estimating excess hospitalization
associated with each respiratory virus.
Methods
Ethics Statement
This study has been approved by the Ethics Committee of Li Ka
Shing Faculty of Medicine, the University of Hong Kong
(EC1880-02).The consent was not required for this study as there
was no personal information collected from subjects.
From October 2003 to September 2006, the study subjects were
recruited from the only two public hospitals located on Hong
Kong Island: Pamela Youde Nethersole Eastern Hospital
(PYNEH) and Queen Mary Hospital (QMH) [16,17]. All the
pediatric patients who were admitted into these two hospitals for
acute respiratory diseases (ARD) on one sampling day of each
week were tested for infection of respiratory viruses by immuno-
fluorescence and culture at the microbiology laboratory of QMH.
In this study the weekly number of age-specific hospital admissions
with laboratory confirmed virus infection was divided by its
population denominator to obtain the ‘‘directly observed rate’’.
This rate was regarded as a true virus associated hospitalization
rate for acute respiratory disease in our study population against
which currently used models can be validated. Specifically,
anonymous data on children aged ,18 years with a discharge
diagnosis of ARD, 460–466 or 480–487 (International Classification of
Diseases, 9
th Revision, Clinical Modification) (ICDCM9) from the two
public hospitals were obtained from the computerized database of
the Hong Kong Hospital Authority with permission. Data for each
record included ICDCM9 codes for up to 4 discharge diagnoses in
addition to the ARD diagnosis, age, gender, dates of admission
and discharge and disposition (alive or dead).
Rate difference model
As previously described, the period of influenza predominance
was defined as a period of two or more consecutive weeks in which
the weekly numbers are greater or equal to 4% of the annual
number of virologically confirmed influenza A and B diagnoses
and less than 2% of the annual number of RSV diagnosis [3]. For
comparison, periods of at least two consecutive weeks in which
both the numbers of RSV and influenza virus diagnoses were less
than 2% of their annual totals were defined as periods of baseline
activity for both viruses. To calculate ARD hospitalization
attributable to influenza, we compared mean hospitalization rates
during the periods of influenza predominance with those during
the baseline periods. The estimate for the whole Hong Kong
Island was made by multiplying the number of ARD hospitaliza-
tions in the two hospitals by the reciprocal of the proportion of
pediatric patients served (i.e. 1/0.725). As RSV, parainfluenza and
adenoviruses have less definable seasonality and their peaks usually
overlapped with those of influenza (Figure S1), we could not find a
satisfying definition for their baseline and predominance periods,
and therefore did not apply the rate difference model to these
viruses.
Poisson Regression Model
As in our previous study, the Poisson regression model with a
log link was used to model the weekly numbers of ARD admissions
[6]. The Poisson model assumes that the mean of hospital
admissions is equal to its variance, but this assumption was not
supported in our data as the variance of hospitalization data was
larger than its mean (termed as over-dispersion of variance), we
therefore adopted a quasi-likelihood method, which allows greater
variance than the conventional Poisson distribution, to adjust for
this over-dispersion [18]. Our model differs in some respects from
the Serfling-Poisson model used by Thompson and colleagues
which adopted a pair of sinusoidal terms to adjust for seasonal
variation of mortality [14]. To make the model more robust to the
effects of less predictable seasonality, we first built a core model to
control the confounders, including long-term trends, seasonal
patterns of ARD admissions and meteorological factors, with
natural cubic spline smoothing functions of time, weekly average
temperature and relative humidity. Smoothing functions were
applied to remove seasonality and long term variations which are
expected to be associated with time-varying confounders. The
goodness of fit of the core model or its adequacy in controlling for
time-varying confounding was judged by a lack of autocorrelation
in its residuals. If there was still autocorrelation after adjusting for
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terms of residuals were added to the core model until the updated
residuals distributed randomly and independently of each other.
The virus activity variables for influenza (type A and B), RSV,
parainfluenza (type I, II and III) and adenovirus were then
simultaneously entered into the core model. The baseline
hospitalization specific for a certain virus was calculated as the
expected hospitalization numbers when the weekly proportions of
that virus were set equal to zero and the observed data of other
variables were simultaneously entered into the Poisson model. In
this baseline level that specified virus was assumed not circulating
in the community while the effects on hospitalization associated
with cold winter, other co-circulating respiratory viruses and other
unknown seasonal factors were represented. The age-specific
excess hospitalization rate for each specified virus was defined as
the difference between the annual sums of observed and virus-
specific baseline hospitalization for each age group divided by the
age-specific population. The 95% confidence intervals of excess
rates were estimated by bootstrapping the residuals of the full
model 1,000 times. A detailed description for Poisson modeling
approach is provided in File S1.
In our previous study, the virus activity was measured by the
weekly proportions of specimens positive for each virus (proportion
variable), respectively. We calculated the proportions based on the
virology data from the microbiology laboratory of QMH which
covered all the age groups on Hong Kong Island. We also
repeated the analysis with the weekly numbers of positive
specimens as an alternative proxy for virus activity (number
variable) in our Poisson models.
The log-link Poisson models have been previously criticized for
assuming that the numbers of hospital admissions increase
exponentially with the proportions of positive isolates [19]. We
therefore also built a Poisson model with an identity link, in which
the hospital admissions increase proportionally with unit increase
of virus activity. The age-specific excess hospitalization rate
associated with influenza derived from each of these Poisson
models was compared with the directly observed rate of influenza
and the model that provided the most accurate estimate for
influenza was chosen for analysis of other respiratory viruses.
Results
The virologically confirmed, population-based age-specific
hospitalization rates for each respiratory virus during these three
study years are shown in Table 1. Among these viruses, influenza
is the only one with frequent antigenic changes. Antigenic drift
variants that appeared during the study period were A/
California/7/04-like (H3N2) virus in 2004–05 and A/HK/
2652/06-like (H1N1) virus in 2005–06 [16]. However, the
H1N1 A/HK/2652/06-like virus did not start to circulate until
the second half of 2006, and therefore had minimal impact on this
study which ended in September 2006.
Influenza associated ARD hospitalization rates
Rate difference model. On the basis of the study definition,
there were four weeks in which influenza predominated in 2003–
04 and 2004–05 seasons whereas there were none in 2004–05
(Figure 1). In 2003–04, 2004–05 and 2005–06, there were 17, 6
and 16 weeks respectively, in which neither influenza virus nor
RSV was active (baseline period). The rate difference model could
not be used for the 2004–05 season since an influenza
predominance period could not be defined. When compared to
the directly observed virologically confirmed influenza
hospitalization rates for each age group, the rate difference
model failed to produce estimates that closely matched the directly
observed incidence rates for the other two years (Table 1 and
Figure 2).
Poisson Regression model. The log-link Poisson models
with the proportion variables yielded the estimates close to the
directly observed rates for the children older than two years, but
the estimates tended to much higher for the ,1 and 1 to ,2 age
groups (Table 1). The identity-link function overestimated the true
disease burden to a greater extent than did the log-link function in
most age-year categories, no matter what influenza proxy variable
was used. The influenza effect for each age group was found to be
statistically significant (p,0.05) in all the models, the only
exception being the ,1 age group in the identity-link Poisson
models with proportion variables (Table 1). Overall, the log-link
models with the number variables provided the estimates closest to
the directly observed rates, despite underestimation observed for
the 2–5 and 5–10 age groups (Figure 2). The log-link Poisson
models with the number variables were chosen for further analysis
for other respiratory viruses.
ARD hospitalization rates associated with other
respiratory viruses
In the age group younger than one year, the estimates of excess
hospitalization rates for parainfluenza were close to those directly
observed from young children, but those for RSV tended to be
lower for the 2003–2004 and 2005–2006 seasons (Table 2). For
children older than 1 year of age, the estimates for excess
hospitalization associated with RSV or parainfluenza derived from
the log-link Poisson model with the number variables had wide
confidence intervals and were markedly deviant from the directly
observed rates. The estimates for adenovirus associated hospital-
ization were unreliable at all ages.
Discussion
As previously suspected, the rate difference model is not
applicable when influenza does not appear as a sharp peak with
reasonable separation from RSV [3]. We further demonstrate that
this model greatly underestimates the actual disease burden (even
when influenza predominant periods are separated from periods of
RSV circulation) if significant influenza activity exists outside the
predominant peak of influenza virus activity, as commonly occurs
in subtropics and tropics. In addition to RSV, other common
respiratory viruses can also have significant confounding effects,
especially on hospitalization of children, and these cannot be
readily accounted for in this model.
In Poisson regression models, the baseline levels of influenza are
predicted from a model fitted to observed numbers of hospital
admissions. The excess hospitalization estimate is robust to
potential confounding effects due to uncontrolled individual
factors that do not change over a short period of time, such as
smoking status and preexisting chronic conditions [20]. Given the
relatively broad and variable seasonality of influenza in the
tropical and subtropical regions such as Hong Kong, it is not
surprising that the Poisson regression model which uses a non-
parametric smoothing function for modeling any pattern of weekly
hospitalization outperformed the rate difference model in our
study. Additionally, the Poisson regression model allows estimation
of disease burden while more efficiently adjusting for co-morbidity
caused by other respiratory viruses and also for confounding of
seasonal variations of hospitalization and meteorological condi-
tions [6]. However, the Poisson regression model has been
criticized for being potentially inadequate in adjustment for
confounding factors, which would result in allocating more
Models for Respiratory Virus Hospitalization
PLoS ONE | www.plosone.org 3 March 2011 | Volume 6 | Issue 3 | e17882variation of hospital admissions to explanatory variables (influenza
virus activity in our model) than they deserve and thereby
overestimate the influenza effects [21]. In this study, we carefully
checked the adequacy of core models in terms of adjusting for
confounding factors. If autocorrelation of weekly hospitalization
data was still detected in the residuals after adjusting for
confounding factors by smoothing, this would suggest that some
unobservable confounding might remained unadjusted for. We
then would further remove the autocorrelation by adding AR
terms of the residuals of core models. In this way, the long-term
and seasonality associated confounding factors were expected to be
well controlled. The close match between Poisson regression
estimates and directly observed numbers suggested that our
control strategy for confounding is appropriate and sufficient.
The debate over log-link Poisson models has focused on
whether it is appropriate to assume the multiplicative risk for
hospitalization or mortality associated with the unit increase of
proportions of positive specimens [9]. Here we did a sensitivity
analysis by using the identity-link Poisson regression model which
assumes the additive risks associated with influenza virus activity.
The results showed that the log-link Poisson generally returned
estimates smaller than those from the identity-link models.
Thompson et al. also found that these two link functions produced
the similar results [9]. But the lack of a clear biological rationale
Table 1. Comparison of influenza associated ARD hospitalization rate (per 10,000) estimated from the rate difference model, log-
link Poisson and identity-link Poisson regression models with virologically confirmed hospitalization (Directly observed) in patients
,18 years on Hong Kong Island.
Age group
Directly
observed Rate difference
Log-link Poisson
(proportion)
a
Log-link Poisson
(case number)
b
Identity-link Poisson
(proportion)
a
Identity-link Poisson
(case number)
b
2003–2004
,1 77.8 11.2 128.7 72.0 104.7 79.6
(29.2, 31.5) (41.5, 207.3) (22.9, 120.0) (215.3, 223.6) (8.7, 150.5)
1-,2 95.5 2.2 145.9 89.6 178.5 121.4
(23.5, 17.5) (64.4, 217.7) (46.7, 136.3) (51.8, 305.1) (51.1, 192.5)
2-,5 67.7 17.0 81.6 47.9 143.1 88.4
(8.7, 25.1) (47.9, 111.8) (27.8, 66.9) (86.9, 199.3) (53.7, 123.1)
5-,10 18.2 2.6 18.9 7.5 22.5 17.0
(20.2, 5.5) (8.7, 28.3) (1.9, 13.6) (1.4, 43.5) (4.4, 29.4)
10-,18 2.7 1.3 5.2 2.3 6.7 4.8
(0.3, 2.2) (1.4, 8.5) (0.1, 4.5) (0.9, 12.5) (1.2, 8.4)
2004–2005
,1 103.8 NA 125.3 109.2 81.9 94.3
(41.0, 203.5) (34.7, 177.5) (211.2, 175.0) (9.9, 178.7)
1-,2 68.2 NA 145.3 137.6 139.3 145.3
(62.9, 220.9) (70.5, 208.2) (40.8, 238.8) (61.2, 229.4)
2-,5 84.6 NA 82.6 72.5 111.7 102.8
(48.1, 114.1) (42.2, 100.4) (67.7, 155.1) (62.4, 143.2)
5-,10 28.2 NA 26.4 16.7 17.6 19.9
(12.0, 39.6) (3.9, 30.1) (1.1, 33.9) (5.2, 34.8)
10-,18 4.6 NA 5.4 3.8 5.1 5.4
(1.4, 9.0) (0.2, 7.3) (0.7, 9.5) (1.4, 9.5)
2005–2006
,1 38.9 9.2 86.1 64.0 61.5 64.0
(251.2, 69.6) (25.8, 141.4) (19.7, 107.0) (28.6, 131.6) (7.4, 121.8)
1-,2 54.6 58.4 116.1 95.4 107.1 100.8
(15.1, 101.4) (48.6, 180.1) (48.6, 145.9) (31.5, 182.8) (42.3, 159.4)
2-,5 63.5 0.8 67.0 51.9 85.4 72.9
(236.2, 37.6) (38.1, 94.0) (30.2, 73.6) (51.9, 118.9) (44.0, 101.2)
5-,10 24.6 3.8 21.6 11.4 13.3 13.9
(22.5, 10) (9.6, 33.1) (2.9, 20.6) (0.8, 25.9) (3.7, 24.3)
10-,18 8.2 0.1 5.2 3.1 3.9 3.9
(21.6, 1.9) (1.3, 8.9) (0.2, 6.0) (0.5, 7.2) (1.0, 6.7)
The 95% confidence interval for each estimate is shown in bracket.
Note:
a Models with the proportions of positive specimens as proxy for influenza activity.
bModels with the numbers of positive specimens as proxy.
doi:10.1371/journal.pone.0017882.t001
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are no epidemiological studies that could provide solid evidence to
support a linear or log-linear relationship between influenza cases
and hospital admissions. As the log-link function ensures a non-
negative estimate for predicted hospital admission numbers, the
log-link Poisson regression model is probably more appropriate for
influenza disease burden studies.
In this study we adopted the quasi-likelihood method in Poisson
models to control over-dispersion of variance in hospitalization
data. The negative binomial model, which is a generalized form of
Poisson models and addresses the over-dispersion problem by a
scale parameter has also been introduced into the influenza disease
burden study [8,15]. We then built the negative binomial model to
estimate influenza associated hospitalization rates of each age-
disease category. The results showed that the estimates of negative
binomial models with a log-link or identity-link tended to be
slightly larger than those of log-link Poisson models in the age
groups younger than 5 years, but the log-link negative binomial
models markedly underestimated the rates in the 5–10 age group,
and influenza effects were found not statistically significant in the
0–1 and 5–10 age groups in the identity-link negative binomial
models (data not shown). These findings suggest the quasi-
likelihood methods performed better than the negative binomial
regression in terms of producing estimates closer to the directly
observed data.
The optimal indicator of virus activity in such studies has also
been contentious. We have previously used the proportion of
specimens positive for influenza as proxy for influenza virus
activity. In this study, we carried out sensitivity analysis by
replacing the positive proportions with the numbers of positive
specimens as the influenza virus activity variable into the models.
Both the log-link and identity-link models with the number
variable generally yielded estimates closer to the directly observed
rates, compared with the models with the proportion variable. Our
virology data were obtained from one laboratory which consis-
tently received 100 to 200 specimens for respiratory virus diagnosis
each week from the patients admitted with acute respiratory
disease and these specimen numbers were driven by clinical need
and were not capped in any way. However, data from a
community influenza-like-illness surveillance program that covers
a city or even larger area, the influenza case numbers may be
subject to bias introduced by pre-determined targets of numbers to
be collected each week. Alternatively, changes in the numbers of
sentinel sites or in health seeking behavior may trigger artificial
changes in specimen numbers. Therefore, the proportion of
positive specimens is likely to be a more robust indicator in such
situations.
A limitation of this study is that the nasopharyngeal specimens
were tested by immunofluorescence and viral culture, not by the
more sensitive polymerase chain reaction (PCR). We found that
immunofluorescence and culture under-estimates influenza cases
by approximately 10% and RSV by 13% [23]. Other studies
reported a 10% to 20% increase of samples positive for RSV and
parainfluenza when PCR was used [24,25]. Hence the directly
observed rates in the present study may underestimate the true
disease burden of these respiratory viruses. Even if we take into
account this potential underestimation of directly observed rates
by multiplying a factor of 10%, the log-link Poisson model with the
Figure 1. Observed (dots) and predicted numbers (solid line) of ARD hospitalization in the 1,-2 age group. The weekly proportions of
specimens positive for influenza are shown in broken line. The baseline and predominance periods defined by the Rate Difference model are
highlighted in light grey and dark grey colors.
doi:10.1371/journal.pone.0017882.g001
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offered the estimates closest to the directly observed rates of
influenza and RSV, and the excess rates for parainfluenza in the
,1 age group were almost equal to the true disease burden.
Although parainfluenza and adenovirus caused substantial
hospitalizations of children in our study, the Poisson model did
not return reliable estimates for these two respiratory viruses, with
the exception of parainfluenza infection in those ,1 year of age.
The poor estimates in older children could be due to relatively low
proportions of samples positive for parainfluenza and adenovirus
from the surveillance network (Figure S1). Compared to influenza
and RSV, these two viruses exhibit less clearly defined seasonal
variations, which may further increase the difficulty in relating the
variation of hospitalizations to the weekly proportions of
parainfluenza and adenovirus.
In our study, the rate difference model tends to provide smaller
estimates of influenza associated disease burden than does the
Poisson model. Interestingly, Thompson et al. found that the rate
difference model consistently returned higher estimates than the
Poisson model in the US [14]. This could be a result of different
definitions adopted by the two studies. Their study did not
consider co-circulation of RSV when they defined baseline and
epidemic periods, largely owing to the overlapping seasonal peaks
of these two viruses in the US [22]. Moreover, the well defined
single peak of influenza in winter in the US would allow a more
accurate estimate from the rate difference model that in a tropical
or subtropical region where the virus activity is more dispersed
throughout the year.
Contrary to our findings, the Canadian study by Gilca et al.
found that estimates derived from both log-link Poisson and rate
difference models significantly underestimated the pneumonia and
influenza admissions with laboratory confirmed influenza in
children of two years old or younger [15]. Their study has the
limitation that laboratory-confirmed diagnoses of influenza and
RSV came from a convenience sample from one hospital that
served 10% of Quebec children and may not represent the
pediatric RSV/influenza epidemiology of the province. In
contrast, our study is based on the data directly derived from
72.5% of all hospitalizations in Hong Kong Island, i.e. the
population denominator. Gilca et al. adjusted for interaction
between influenza and RSV by adding a product term into their
Poisson models. We did a sensitivity analysis with the same
approach and the results showed that influenza effects changed
only marginally and the RSV estimates remained nearly
unchanged (data not shown). Therefore, we did not need to
include any interaction term in our full models.
Poisson regression models very accurately estimated the excess
rate for influenza in the 2–18 year old age groups, but the influenza
estimates for the children younger than two years were much higher
than the directly observed rates. Interestingly,the estimatesfor RSV
were accordingly lower in the young children. As the peaks of
influenza and RSV occasionally overlapped in the study period, it is
possible that such under- and over-estimate could be the result of
multicollinearity between virus variables in our Poisson models. We
then did a sensitivity analysis by assessing the effects of single virus
without adjustment for co-circulation of other viruses, i.e. only one
virus variable being entered into the model. The results showed that
the influenza estimates slightly increased after model change with
the exception of the 2-,5 age group. The RSV associated rates
slightly increased for the 1-,2a n d5 ,-10 age groups and but
decreased for the children younger than 1 year old (Table S1). The
Poisson estimates for parainfluenza and adenovirus without
Figure 2. Comparison of age-year specific influenza-associated excess ARD hospitalization rates. The estimates from the log-link
Poisson regression with the proportion variables (open circle) and identity-link Poisson with the proportion variables (open triangle) and log-link
Poisson with the case number variables (solid circle) and identity-link Poisson models with the case number variables (solid triangle) were plotted
against directly observed hospitalization rates with diagnosis of influenza infection. A linear regression line was separately fitted to the estimates
derived from each model. The thick black line is the diagonal for y=x.
doi:10.1371/journal.pone.0017882.g002
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pared to the full models) but this is more likely due to the unstable
natureoftheseestimatesasshownintheirwideconfidenceintervals.
The results indicate a mild extent of collinearity between influenza
and RSV variables, which may not significantly affect our estimates.
Some of the confidence intervals for estimated age-specific rates of
influenza associated hospitalization tended to be rather wide,
presumably due to the fact that the study covered a period of only
three years. We would expect to get narrower confidence intervals
with longer time series, although it is difficult to sustain the
systematic virological diagnosis of all ARD admissions on an
ongoing basis to provide the virologically confirmed independent
validation of the estimates.
In conclusion, Poisson regression modeling is applicable to the
assessment of disease burden due to influenza associated
hospitalization in children. It also yields reasonable estimates for
RSV and parainfluenza in children ,1 year of age, but performs
less well for the older children. None of these methods provided
reliable estimates of disease burden for adenovirus hospitalization.
Although mortality was not assessed and could not be validated in
this study, we could infer that the good correlation between the
output of the Poisson model and virologically confirmed
hospitalization will also be applicable to mortality estimates. Such
an approach to estimation of influenza disease burden requires
long-term virological surveillance data and thereby restricts its
application in some geographic regions. However, with the
Table 2. The ARD hospitalization rate (per 10,000) associated with respiratory syncytial virus (RSV), parainfluenza and adenovirus
in patients ,18 years on Hong Kong Island.
Age 2003–04 2004–05 2005–06
Directly
observed
Poisson regression
(95% CI)
Directly
observed
Poisson regression
(95% CI)
Directly
observed
Poisson regression
(95% CI)
RSV
,1 155.6 135.3 168.5 234.5 233.4 157.4
(77.5, 192.0) (136.5, 328.9) (89.8, 222.6)
1-,2 81.8 37.8 163.7 72.2 54.6 50.4
(223.7, 10 4.4) (249.3, 191.2) (232.4, 142.2)
2-,5 59.2 12.2 38.1 24.4 33.9 17.1
(214.2, 37.6) (228.5, 71.9) (219.7, 52.6)
5-,10 1.8 9.2 3.6 23.8 1.8 17.8
(0.6, 16.3) (1.6, 41.4) (1.0, 32.3)
10-,18 0.0 2.7 0.0 5.4 0.0 4.8
(20.2, 5.2) (20.4, 10.0) (20.3, 9.1)
Parainfluenza
,1 64.8 70.9 103.7 121.6 90.8 107.0
(7.6, 128.7) (37.2, 196.1) (1.2, 195.5)
1-,2 81.8 216.3 150.1 4.2 54.6 225.2
(292.6, 54.8) (295.2, 95.2) (2150.4, 88.2)
2-,5 29.6 17.6 50.8 13.7 63.5 48.0
(29.3, 43.5) (233.9, 57.0) (22.0, 97.2)
5-,10 5.5 24.6 3.6 26.8 9.1 27.6
(213.9, 4.3) (224.6, 10.4) (230.2, 15.3)
10-,18 0.9 22.2 0.0 22.7 0.0 24.1
(25.6, 1.0) (27.3, 1.8) (211.9, 3.1)
Adenovirus
,1 13.0 23.3 77.8 216.1 25.9 27.4
(230.5, 25.1) (2146.4, 112.9) (268.9, 55.3)
1-,2 13.6 14.8 54.6 69.7 13.6 35.1
(214.8, 44.4) (273.1, 194.6) (234.2, 103.5)
2-,5 38.1 23.4 59.2 216.6 38.1 210.5
(217.1, 8.8) (285.6, 42.8) (253.2, 27.6)
5-,10 1.8 1.2 21.8 8.1 9.1 4.7
(22.8, 4.9) (219.2, 29.6) (210.6, 17.6)
10-,18 0.0 0.5 0.0 2.3 0.9 1.7
(20.8, 1.7) (24.0, 7.7) (22.7, 5.9)
The estimates from the log-link Poisson models were compared with virologically confirmed hospitalization (Directly observed).
doi:10.1371/journal.pone.0017882.t002
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influenza H5N1, and now from the recent pandemic H1N1, such
virological data is becoming increasingly available in many
countries making Poisson regression modelling feasible in an
increasing number of contexts.
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